Published in Br J Cancer on March 26, 2007
Tailoring to RB: tumour suppressor status and therapeutic response. Nat Rev Cancer (2008) 3.16
AR, the cell cycle, and prostate cancer. Nucl Recept Signal (2008) 2.44
Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer. Clin Cancer Res (2009) 1.17
Effect of low-fat diet on development of prostate cancer and Akt phosphorylation in the Hi-Myc transgenic mouse model. Cancer Res (2008) 1.16
alpha-Catenin overrides Src-dependent activation of beta-catenin oncogenic signaling. Mol Cancer Ther (2008) 0.97
The AR dependent cell cycle: mechanisms and cancer relevance. Mol Cell Endocrinol (2011) 0.93
Cyclin D1 is a selective modifier of androgen-dependent signaling and androgen receptor function. J Biol Chem (2011) 0.92
Epigenetically altered miR-193b targets cyclin D1 in prostate cancer. Cancer Med (2015) 0.92
Dissecting the expression of EEF1A1/2 genes in human prostate cancer cells: the potential of EEF1A2 as a hallmark for prostate transformation and progression. Br J Cancer (2011) 0.92
In the wrong place at the wrong time: does cyclin mislocalization drive oncogenic transformation? Nat Rev Cancer (2013) 0.89
Tumor-suppressive microRNA-145 induces growth arrest by targeting SENP1 in human prostate cancer cells. Cancer Sci (2015) 0.88
Characterization of cytoplasmic cyclin D1 as a marker of invasiveness in cancer. Oncotarget (2016) 0.82
Cyclin D1 expression in prostate carcinoma. Braz J Med Biol Res (2014) 0.81
Aminomethylphosphonic acid inhibits growth and metastasis of human prostate cancer in an orthotopic xenograft mouse model. Oncotarget (2016) 0.78
Role of cyclin D1 immunoreactivity and AgNOR staining in the evaluation of benign and malignant lesions of the prostate. Prostate Int (2014) 0.77
Protein mislocalization: mechanisms, functions and clinical applications in cancer. Biochim Biophys Acta (2014) 0.76
Cell-specific Kaiso (ZBTB33) Regulation of Cell Cycle through Cyclin D1 and Cyclin E1. J Biol Chem (2016) 0.76
Expression of p-Akt in ovarian serous carcinoma and its association with proliferation and apoptosis. Oncol Lett (2013) 0.75
Interleukin-9 promotes cell survival and drug resistance in diffuse large B-cell lymphoma. J Exp Clin Cancer Res (2016) 0.75
miR-30e* is overexpressed in prostate cancer and promotes NF-κB-mediated proliferation and tumor growth. Oncotarget (2017) 0.75
Cancer statistics, 2006. CA Cancer J Clin (2006) 30.71
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature (1999) 20.34
Molecular determinants of resistance to antiandrogen therapy. Nat Med (2003) 18.90
Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev (1998) 12.55
The development of androgen-independent prostate cancer. Nat Rev Cancer (2001) 11.88
Living with or without cyclins and cyclin-dependent kinases. Genes Dev (2004) 6.54
The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J (1999) 5.44
Minireview: Cyclin D1: normal and abnormal functions. Endocrinology (2004) 5.22
Expression and amplification of cyclin genes in human breast cancer. Oncogene (1993) 3.79
Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev (2000) 3.72
Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence. J Cell Biochem (2004) 3.51
Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. Cancer Res (1999) 3.41
Akt-regulated pathways in prostate cancer. Oncogene (2005) 3.35
Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol Cell Biol (1995) 3.16
Control of pRB phosphorylation. Curr Opin Genet Dev (1998) 2.49
Linking cyclins to transcriptional control. Gene (2002) 2.49
Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins. Cancer Res (2006) 2.46
Cyclin D1 in breast cancer pathogenesis. J Clin Oncol (2005) 2.36
An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene. Cancer Res (2003) 2.21
A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase. Mol Cell Biol (1997) 2.14
PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1. Mol Cell Biol (2003) 2.14
Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer. Clin Cancer Res (2005) 1.90
Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci U S A (1993) 1.84
Multiple G1 regulatory elements control the androgen-dependent proliferation of prostatic carcinoma cells. J Biol Chem (1998) 1.79
Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone. Clin Cancer Res (2000) 1.75
Chemistry and structural biology of androgen receptor. Chem Rev (2005) 1.72
Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner. Mol Endocrinol (2001) 1.71
p21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells. J Biol Chem (2003) 1.70
Association of cyclin D1 expression with factors correlated with tumor progression in human hepatocellular carcinoma. J Gastroenterol (1999) 1.70
D-type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability. Cancer Res (1999) 1.67
Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells. J Steroid Biochem Mol Biol (2005) 1.67
Location, location, location: the role of cyclin D1 nuclear localization in cancer. J Cell Biochem (2005) 1.63
Prostate cancer cell cycle regulators: response to androgen withdrawal and development of androgen independence. J Natl Cancer Inst (1999) 1.63
Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. Mol Cell Biol (1999) 1.58
p21(Cip1) Promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export. J Biol Chem (2001) 1.53
Androgen regulation of the cyclin-dependent kinase inhibitor p21 gene through an androgen response element in the proximal promoter. Mol Endocrinol (1999) 1.53
Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation. Proc Natl Acad Sci U S A (2006) 1.52
Update on the Gleason grading system for prostate cancer: results of an international consensus conference of urologic pathologists. Adv Anat Pathol (2006) 1.51
The activities of cyclin D1 that drive tumorigenesis. Trends Mol Med (2004) 1.50
Metaplastic carcinoma of the breast with osteocartilaginous heterologous elements. Am J Surg Pathol (1998) 1.32
Ubiquitination of free cyclin D1 is independent of phosphorylation on threonine 286. J Biol Chem (2000) 1.25
Discovery of new DNA amplification loci in prostate cancer by comparative genomic hybridization. Prostate (2001) 1.23
Cyclin D1 Is a Ligand-independent Co-repressor for Thyroid Hormone Receptors. J Biol Chem (2002) 1.23
Androgen receptor corepressors and prostate cancer. Endocr Relat Cancer (2006) 1.17
Expression of androgen receptor coregulators in prostate cancer. Clin Cancer Res (2004) 1.17
Cyclin D1 binding to the androgen receptor (AR) NH2-terminal domain inhibits activation function 2 association and reveals dual roles for AR corepression. Mol Endocrinol (2004) 1.16
Inactivation of the p53 pathway in prostate cancer: impact on tumor progression. Clin Cancer Res (1999) 1.13
Prognostic and predictive value of p53 and p21 in breast cancer. Breast Cancer Res Treat (1998) 1.13
Subcellular localisation of cyclin D1 protein in colorectal tumours is associated with p21(WAF1/CIP1) expression and correlates with patient survival. Int J Cancer (2001) 1.13
A central domain of cyclin D1 mediates nuclear receptor corepressor activity. Oncogene (2005) 1.12
Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Aberdeen Colorectal Initiative. Int J Cancer (2000) 1.08
Expression of cell cycle markers in colorectal carcinoma: superiority of cyclin A as an indicator of poor prognosis. Int J Cancer (1999) 1.08
Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expression. Br J Cancer (1999) 1.07
The cyclin D1 proto-oncogene is sequestered in the cytoplasm of mammalian cancer cell lines. Mol Cancer (2006) 1.07
Specificity of cyclin D1 for androgen receptor regulation. Cancer Res (2003) 1.06
The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma. Cancer (1997) 1.05
Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors. Prostate (1998) 1.04
The association of p21((WAF-1/CIP1)) with progression to androgen-independent prostate cancer. Clin Cancer Res (2002) 1.04
Expression of cyclin D1 and retinoblastoma protein in colorectal cancer. Eur J Cancer (1998) 1.03
Expression of transforming growth factor-beta-1 and p27Kip1 in pancreatic adenocarcinomas: relation with cell-cycle-associated proteins and clinicopathologic characteristics. BMC Cancer (2005) 0.99
Molecular biology of laryngeal squamous cell carcinoma. Virchows Arch (2002) 0.98
Ras-induced colony formation and anchorage-independent growth inhibited by elevated expression of Puralpha in NIH3T3 cells. J Cell Biochem (2001) 0.98
Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors. Clin Cancer Res (1999) 0.97
Expression of cyclin A and D proteins in prostate cancer and their relation to clinopathological variables and patient survival. Prostate (1999) 0.96
A comparative study of the expression of Wnt-1, WISP-1, survivin and cyclin-D1 in colorectal carcinoma. Int J Colorectal Dis (2005) 0.95
Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67. Br J Cancer (2001) 0.94
Calmodulin and cyclin D anchoring sites on the Src-suppressed C kinase substrate, SSeCKS. Biochem Biophys Res Commun (2002) 0.93
Differential requirements for ras and the retinoblastoma tumor suppressor protein in the androgen dependence of prostatic adenocarcinoma cells. Cell Growth Differ (2000) 0.93
Tumour suppressor genes in prostate cancer. Semin Cancer Biol (1997) 0.92
Expression and subcellular localization of cyclin D1 protein in epithelial ovarian tumour cells. Br J Cancer (1999) 0.91
Histopathologic and biologic characteristics of a transitional cell carcinoma with inverted papilloma-like endophytic growth pattern. Urology (2003) 0.91
High Pin1 expression is associated with tumor progression in colorectal cancer. J Surg Oncol (2006) 0.91
The PSA era is not over for prostate cancer. Eur Urol (2005) 0.87
Relationship of p21(WAF-I) protein expression with prognosis in advanced prostate cancer treated by androgen ablation. Prostate (2001) 0.86
Prognostic value of cyclin D1 overexpression in correlation with pRb and p53 status in non-small cell lung cancer (NSCLC). J Cancer Res Clin Oncol (2005) 0.86
Relationship of p21(WAF1) expression with disease-free survival and biochemical recurrence in prostate adenocarcinomas (PCa). Prostate (1999) 0.85
Genesis of pituitary adenomas: state of the art. J Neurooncol (2001) 0.85
Overexpression of cyclin D1 is rare in human prostate carcinoma. Prostate (1999) 0.85
Expression of p21 cell cycle protein is an independent predictor of response to salvage radiotherapy after radical prostatectomy. Prostate (2004) 0.84
Targeted therapies for prostate cancer. Expert Opin Ther Targets (2005) 0.83
Immunohistochemical study of p21WAF1 and p53 proteins in prostatic cancer and their prognostic significance. Hum Pathol (1998) 0.82
Relation of Bcl-2 expression to androgen receptor, p21WAF1/CIP1, and cyclin D1 status in prostate cancer. Mol Pathol (2000) 0.82
Cyclin D1 protein expression in human thyroid gland and thyroid cancer. Anat Histol Embryol (2006) 0.81
Cytoplasmic sequestration of cyclin D1 associated with cell cycle withdrawal of neuroblastoma cells. Biochem Biophys Res Commun (2005) 0.80
Characterization of t(11;14) translocation in mantle cell lymphoma by fluorescent in situ hybridization. Oncogene (1996) 0.80
Aberrant expression of G(1)/S regulators is a frequent event in sporadic pituitary adenomas. Carcinogenesis (2001) 0.79
Hormone refractory prostate cancer: Management and advances. Cancer Treat Rev (2006) 0.78
Molecular mechanisms of prostate cancer. Eur J Cancer (2001) 0.77
Expression of p21 and mutant p53 gene products in residual prostatic tumor cells after radical radiotherapy. Prostate (1997) 0.76
Ragweed immunotherapy in adult asthma. N Engl J Med (1996) 4.69
Transcriptional silencing of Ty1 elements in the RDN1 locus of yeast. Genes Dev (1997) 4.31
Exposure-response analysis of mortality among coal miners in the United States. Am J Ind Med (1995) 2.50
An EEG should not be obtained routinely after first unprovoked seizure in childhood. Neurology (2000) 2.27
Latent period for malignant mesothelioma of occupational origin. J Occup Med (1992) 2.16
BRG-1 is required for RB-mediated cell cycle arrest. Proc Natl Acad Sci U S A (2000) 1.85
Ohio drinking water source and cancer rates. Am J Public Health (1977) 1.76
Ionizing irradiation and the induction of clinically significant disease in the human thyroid gland. Am J Med (1977) 1.61
Evaluation of a possible association of urban air toxics and asthma. Environ Health Perspect (1995) 1.52
The medical aspects of soccer injury epidemiology. Am J Sports Med (1987) 1.44
Speedy: a novel cell cycle regulator of the G2/M transition. EMBO J (1999) 1.42
Comparison of tenoxicam by intramuscular injection or wound infiltration for analgesia after inguinal herniorrhaphy. Anesth Analg (1996) 1.40
Skin and eye diseases among arc welders those exposed to welding operations. J Occup Med (1981) 1.39
The epidemiology of genital colonization with Staphylococcus aureus. Ann Intern Med (1982) 1.32
Thyroid carcinoma in Hiroshima and Nagasaki. I. Prevalence of thyroid carcinoma at autopsy. JAMA (1969) 1.30
Antibody responses to toxic-shock-syndrome (TSS) toxin by patients with TSS and by healthy staphylococcal carriers. J Infect Dis (1984) 1.28
Cancer incidence among workers in the Norwegian ferroalloy industry. Br J Ind Med (1986) 1.26
Demonstration to medical students of placebo responses and non-drug factors. Lancet (1972) 1.25
Fetal and infant lead exposure: effects on growth in stature. Pediatrics (1989) 1.24
A prospective 15-year follow up of 154 consecutive patients with trigeminal neuralgia treated by percutaneous stereotactic radiofrequency thermal rhizotomy. J Neurosurg (1995) 1.18
Cyclin D1 binding to the androgen receptor (AR) NH2-terminal domain inhibits activation function 2 association and reveals dual roles for AR corepression. Mol Endocrinol (2004) 1.16
Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome. Oncogene (2009) 1.15
Relationship between socioeconomic factors and severe childhood injuries. J Urban Health (2001) 1.14
The National Cancer Institute Cooperative Early Lung Cancer Detection Program. Results of the initial screen (prevalence). Early lung cancer detection: Introduction. Am Rev Respir Dis (1984) 1.14
Effects of varying content of soluble dietary fibre from wheat flour and oat milling fractions on gastric emptying in pigs. Br J Nutr (1996) 1.10
Targeting cell cycle and hormone receptor pathways in cancer. Oncogene (2013) 1.10
Separation of phenotypes in mutant alleles of the Schizosaccharomyces pombe cell-cycle checkpoint gene rad1+. Mol Biol Cell (1995) 1.09
Function changes in spinal muscular atrophy II and III. The DCN/SMA Group. Neurology (1996) 1.05
Familial combined hyperlipoproteinemia: studies in 91 adults and 95 children from 33 kindreds. Metabolism (1973) 1.05
Lead exposure and neurobehavioral development in later infancy. Environ Health Perspect (1990) 1.05
Retinoblastoma tumor suppressor protein signals through inhibition of cyclin-dependent kinase 2 activity to disrupt PCNA function in S phase. Mol Cell Biol (2001) 1.05
Prospective analysis of strength in spinal muscular atrophy. DCN/Spinal Muscular Atrophy Group. J Child Neurol (2000) 1.03
Rubella antibody levels in juvenile rheumatoid arthritis. Ann Rheum Dis (1975) 0.97
Cyclin D1 promotes anchorage-independent cell survival by inhibiting FOXO-mediated anoikis. Cell Death Differ (2009) 0.96
Cluster analysis applied to building-related illness. J Occup Environ Med (1998) 0.96
The influence of dietary fibre source and level on the development of the gastrointestinal tract, digestibility and energy metabolism in broiler chickens. Br J Nutr (1996) 0.95
Smallest forms of papillary carcinoma of the thyroid. A study of 141 microcarcinomas less than 0.1 cm in greatest dimension. Arch Pathol (1971) 0.94
Cyclin D1 repressor domain mediates proliferation and survival in prostate cancer. Oncogene (2008) 0.94
Hyperlipemia in progeny of parents with myocardial infarction before age 50. Am J Dis Child (1974) 0.94
Differential requirements for ras and the retinoblastoma tumor suppressor protein in the androgen dependence of prostatic adenocarcinoma cells. Cell Growth Differ (2000) 0.93
Metastases from occult thyroid carcinoma. An autopsy study from Hiroshima and Nagasaki, Japan. Cancer (1970) 0.91
Xenoestrogen action in breast cancer: impact on ER-dependent transcription and mitogenesis. Breast Cancer Res Treat (2005) 0.91
Elevated cyclins and cyclin-dependent kinase activity in the rhabdomyosarcoma cell line RD. Cancer Res (1998) 0.90
Bivariate analyses of cholesterol and triglyceride levels in families in which probands have type IIb lipoprotein phenotype. Am J Hum Genet (1975) 0.90
Proportional mortality analysis of wastewater treatment system workers by birthplace with comments on amyotrophic lateral sclerosis. J Occup Med (1994) 0.90
Familial hypertriglyceridemia: studies in 130 children and 45 siblings of 36 index cases. Metabolism (1973) 0.89
Gastric xanthelasma. Arch Pathol (1969) 0.88
Cardiac tamponade: a comparison of right versus left heart compression. J Am Coll Cardiol (1988) 0.88
Prospective study of spinal muscular atrophy before age 6 years. DCN/SMA Group. Pediatr Neurol (1993) 0.87
Pulmonary function in spinal muscular atrophy. J Child Neurol (1994) 0.87
Birthplace as a risk factor in motor neurone disease and Parkinson's disease. Int J Epidemiol (1993) 0.86
Cigarette smoking and duration of pregnancy. Am J Obstet Gynecol (1969) 0.85
Cyclin D3 action in androgen receptor regulation and prostate cancer. Oncogene (2007) 0.84
Consequences of smoking and caffeine consumption during pregnancy in women with type 1 diabetes. J Matern Fetal Neonatal Med (2004) 0.84
Hospital characteristics, diagnoses, and staff reasons associated with use of seclusion and restraint. Hosp Community Psychiatry (1993) 0.83
The nutritive value of amaranth grain (Amaranthus caudatus). 3. Energy and fibre of raw and processed grain. Plant Foods Hum Nutr (1990) 0.83
Relationship of air lead and blood lead for workers at an automobile battery factory. Int Arch Occup Environ Health (1982) 0.83
Atlantooccipital junction: standards for measurement in normal children. AJNR Am J Neuroradiol (1988) 0.83
Determination of urinary mandelic and phenylglyoxylic acids in styrene exposed workers and a control population. Am Ind Hyg Assoc J (1980) 0.82
Radiation-associated carcinoma of the salivary glands. A controlled study. Ann Otol Rhinol Laryngol (1981) 0.81
Intestinal cadmium permeability in mature and immature rats. Proc Soc Exp Biol Med (1991) 0.80
Abnormal finding on a screening endomyocardial biopsy. Am J Transplant (2012) 0.80
Retrieval of p53 protein in paraffin-embedded head and neck tumor tissues. Arch Otolaryngol Head Neck Surg (1993) 0.79
Enhanced development of mammary tumors in rats following transplacental and neonatal exposure to ethylnitrosourea. Cancer Res (1978) 0.79
Clinically important radiation-associated thyroid disease. A controlled study. JAMA (1980) 0.79
Statistics in sports injury research. Am J Sports Med (1988) 0.79
Endocrine disrupting compounds and prostate cancer. Cancer Lett (2005) 0.79
Effects of reducing the starch content in oat-based diets with cellulose on jejunal flow and absorption of glucose over an isolated loop of jejunum in pigs. Br J Nutr (1994) 0.79
Maternal ABO groups and the sex ratio of live births. Hum Hered (1975) 0.79
Papillary carcinoma of the thyroid gland. Sizes of 525 tumors found at autopsy in Hiroshima and Nagasaki. Cancer (1970) 0.78
Spinal muscular atrophy: new thoughts on the pathogenesis and classification schema. J Child Neurol (1992) 0.77
Ondansetron reduces nausea and vomiting after paediatric adenotonsillectomy. Paediatr Anaesth (1997) 0.76
Length of time spent in seclusion and restraint by patients at 82 VA medical centers. Hosp Community Psychiatry (1992) 0.76
Schistosoma japonicum and Trichuris suis infections in pigs fed diets with high and low protein. Parasitology (1997) 0.76
The impact of diets varying in carbohydrates resistant to endogenous enzymes and lignin on populations of Ascaris suum and Oesophagostomum dentatum in pigs. Parasitology (1997) 0.76
Nitrous oxide: an ageing gentleman. Acta Anaesthesiol Scand (2001) 0.75
Possible misclassification did not obscure detection of exposure-response. Am J Ind Med (1996) 0.75
On professor Okun's paper. Am J Public Health (1976) 0.75
Those confounding variables! J Pediatr (1998) 0.75
Nutritive value of cereal products with emphasis on the effect of milling. World Rev Nutr Diet (1989) 0.75
A syndrome of hereditary tyrosinemia in mink (Mustela vison Schreb.). Can J Comp Med (1979) 0.75
Did formaldehyde cause lung cancer? J Occup Med (1989) 0.75
[Pre-hospital care]. Ugeskr Laeger (1989) 0.75
Comparison of the biodistribution of free or liposome-entrapped Crotalus durissus terrificus (South American rattlesnake) venom in mice. Comp Biochem Physiol C Toxicol Pharmacol (2002) 0.75
Therapeutic responses of spontaneous canine malignancies to combinations of radiotherapy and hyperthermia. Int J Radiat Oncol Biol Phys (1991) 0.75
[Lupic nephropathy in childhood: morphologic analysis of 18 cases]. J Pediatr (Rio J) (2003) 0.75
Insulin, obesity, and triglyceride interrelationships in sixteen children with familial hypertriglyceridemia. Pediatr Res (1977) 0.75
Health records. Science (1977) 0.75
The exposure metric: does including time since exposure in the calculation of working lifetime exposure provide a better understanding of disease risk than the cumulative exposure? Med Lav (2011) 0.75
Analysis of alpha-lipoprotein cholesterol in 50 microl of plasma. J Lipid Res (1974) 0.75
National Cancer Institute study: evaluation of computed tomography in the diagnosis of intracranial neoplasms. II. Was randomization necessary? Radiology (1980) 0.75
The effect of amino acid imbalance on nitrogen retention (biological value) in rats. Br J Nutr (1981) 0.75
[Serotonin antagonists in the treatment of postoperative nausea and vomiting]. Ugeskr Laeger (1998) 0.75
The golden fleece award: a control? Science (1977) 0.75
A young man with 20 years of nephrotic range proteinuria without loss of renal function. Am J Kidney Dis (2001) 0.75
Pneumopericardium associated with high-frequency jet ventilation during laser surgery of the hypopharynx in a child. Eur J Anaesthesiol (1997) 0.75
The influence of dietary crude fibre and microbial activity in the digestive tract on true protein digestibility and biological value in rats. Z Tierphysiol Tierernahr Futtermittelkd (1983) 0.75
Orthotopic liver transplantation in a patient with primary pulmonary hypertension. Anaesth Intensive Care (1996) 0.75